Table 1. Baseline patient demographics and clinical characteristics.
Variable | Surgery ( n = 57) |
Neoadjuvant chemotherapy and POCRT ( n = 14) | Surgery and PORT ( n = 73) | Surgery and POCRT ( n = 8) | p -Value | |
---|---|---|---|---|---|---|
Age (y) | Mean ± SD | 63 ± 13 | 59 ± 12 | 65 ± 11 | 61 ± 14 | 0.28 |
Gender | Male | 25 (44) | 5 (36) | 33 (45) | 2 (25) | 0.66 |
Female | 32 (56) | 9 (64) | 40 (55) | 6 (75) | ||
Site | Nasal cavity | 47 (82) | 5 (36) | 61 (84) | 6 (75) | 0.003 |
Paranasal sinuses | 10 (18) | 9 (64) | 12 (16) | 2 (25) | ||
T classification | 3 | 36 (63) | 5 (36) | 51 (70) | 4 (50) | 0.07 |
4a | 20 (35) | 8 (57) | 23 (30) | 3 (38) | ||
4b | 1 (2) | 1 (7) | 0 | 1 (12) | ||
N classification | N0 | 48 (84) | 11 (78) | 69 (94) | 6 (75) | 0.09 |
N+ | 9 (16) | 3 (22) | 4 (6) | 2 (25) | ||
Mitosis | <1 mm 2 | 41 (72) | 9 (64) | 55 (75) | 5 (63) | 0.76 |
≥1 mm 2 | 16 (28) | 5 (36) | 18 (25) | 3 (37) | ||
Ulceration | Present | 43 (75) | 11 (79) | 59 (80) | 5 (63) | 0.67 |
Absent | 14 (25) | 3 (21) | 14 (20) | 3 (37) | ||
Follow-up (mo) | Mean ± SD | 44 ± 5 | 37 ± 14 | 57 ± 6 | 55 ± 19 | 0.39 |
Abbreviations: CRT, chemoradiation therapy; POCRT, postoperative chemoradiation; PORT, postoperative radiotherapy; RT, radiotherapy; SD, standard deviation.